Mortality News and Research

RSS

A study on hospitalized COVID-19 patients who received plasma therapy

A new study has been published which focuses on the evaluation of the outcomes of infected COVID-19 patients who were treated with CCP therapy.

23 Jun 2021

Study shows equitable allocation strategies for SARS-CoV-2 vaccines have a comparative edge

In a recent paper, US researchers demonstrate that equitable distributions of vaccines against COVID-19 are a very optimal approach.

23 Jun 2021

At Texas border, pandemic’s high toll lays bare gaps in health and insurance

Alfredo "Freddy" Valles was an accomplished trumpeter and a beloved music teacher for nearly four decades at one of the city's poorest middle schools.

23 Jun 2021

Health care leaders call for action to prevent non-ventilator-associated, hospital-acquired pneumonia

A group of health care leaders, including a University of Massachusetts Amherst nurse innovator, has published a national call to action to prevent non-ventilator-associated, hospital-acquired pneumonia (NVHAP).

23 Jun 2021

Engineering nanobodies to fight against the SARS-CoV-2 virus

Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants in two different ways.

22 Jun 2021

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

A team of scientists from the Pennsylvania State University, USA, recently analyzed the pharmacodynamics and pharmacokinetics of antiviral drug remdesivir using computational models. Based on the study findings, which are yet to be peer-reviewed, the scientists recommend that for effective inhibition of SARS-CoV-2 infection, remdesivir should be used with other antiviral medicines, or its dosing regimen should be optimized to improve bioavailability.

22 Jun 2021

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

21 Jun 2021

Dissatisfaction with married life increases men's risk of death from stroke and premature mortality

Dissatisfaction with married life raises the risk of dying from a cerebrovascular accident: A new Tel Aviv University study reveals that perceiving marriage as unsuccessful is a significant predictor of death from a CVA and premature death among men, no less that well-known risk factors such as smoking and lack of physical activity.

21 Jun 2021

University of Louisville receives NIH funding to support research into liver-related illness

The University of Louisville Hepatobiology and Toxicology Center of Biomedical Research Excellence has received $11.3 million in funding from the National Institutes of Health to support its research into liver-related illness for an additional five years.

21 Jun 2021

COVID-19 studies should provide sex-disaggregated data, researchers warn

Researchers have warned that studies examining sex-specific responses to infection with SARS-CoV-2 must provide sex-disaggregated data.

21 Jun 2021

Strategies against the development of SARS-CoV-2 vaccine escape mutants

In a recent paper the impact of a number of vaccination strategies is assessed with regards to the probability of inducing a SARS-CoV-2 vaccine escape mutants.

21 Jun 2021

Zinc inhibits SARS-CoV-2’s main protease in vitro

Zinc has antiviral properties. However, the detailed kinetics and the mechanism of zinc in the inhibition of viruses, particularly SARS-CoV-2 – the causative virus of COVID-19 – is unclear. To probe the role of zinc as an anti-SARS-CoV-2 agent at the structural and molecular level, researchers in India studied the binding kinetics and the inhibition mechanism of zinc with SARS-CoV-2’s viral proteins.

21 Jun 2021

COVID-19 vaccine uptake low among pregnant women in U.S., study finds

Despite the availability of vaccines, the U.S. CDC reports that there has been a lack of pregnant women who are getting vaccinated against SARS-CoV-2.

21 Jun 2021

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

A recent study discusses the findings of a study on patients with hematologic cancers who received convalescent plasma therapy following their diagnosis of COVID-19.

21 Jun 2021

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a regimen of at least six months of antimicrobial drugs, and drug-resistant TB is an increasing public health threat.

21 Jun 2021

New program reveals high burden of undiagnosed or poorly controlled diseases in rural South Africa

A comprehensive health-screening program in rural northern KwaZulu-Natal, South Africa, has found a high burden of undiagnosed or poorly controlled non-communicable diseases, according to a study published in The Lancet Global Health.

21 Jun 2021

Novel vaccine based on mRNA technology protects against malaria in animal models

Scientists from the Walter Reed Army Institute of Research and Naval Medical Research Center partnered with researchers at the University of Pennsylvania and Acuitas Therapeutics to develop a novel vaccine based on mRNA technology that protects against malaria in animal models, publishing their findings in npj Vaccines.

18 Jun 2021

Mortality News and Research

A study on hospitalized COVID-19 patients who received plasma therapy

Study shows equitable allocation strategies for SARS-CoV-2 vaccines have a comparative edge

At Texas border, pandemic’s high toll lays bare gaps in health and insurance

Health care leaders call for action to prevent non-ventilator-associated, hospital-acquired pneumonia

Engineering nanobodies to fight against the SARS-CoV-2 virus

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Dissatisfaction with married life increases men's risk of death from stroke and premature mortality

University of Louisville receives NIH funding to support research into liver-related illness

COVID-19 studies should provide sex-disaggregated data, researchers warn

Strategies against the development of SARS-CoV-2 vaccine escape mutants

Zinc inhibits SARS-CoV-2’s main protease in vitro

COVID-19 vaccine uptake low among pregnant women in U.S., study finds

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

New program reveals high burden of undiagnosed or poorly controlled diseases in rural South Africa

Novel vaccine based on mRNA technology protects against malaria in animal models

Study explores COVID-19 outcomes in people with RA

New hydrogel prevents the formation of adhesions after cardiac surgery

Study provides insight into factors that may contribute to men's suicide vulnerability

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News